Excel Industries Q1 FY27: Stable EBITDA, Contract Manufacturing Ramp
Ask Iris
Frequently Asked Questions
Standalone revenue was Rs 293.7 crore, EBITDA was Rs 42.4 crore and PAT was Rs 29.1 crore in Q1 FY27.
Standalone EBITDA margin increased to 14.4% in Q1 FY27 from 13.7% in Q1 FY26, as per the presentation.
The presentation attributes the year-on-year PAT decline mainly to lower non-operating income or other income versus Q1 FY26.
The dedicated manufacturing project was completed on 23 July 2026 with planned capex of Rs 40 crore and a customer trade advance of Rs 25 crore, supporting a 5-year supply agreement.
The company plans a 1,265 MTPA specialty chemical facility at Lote with investment of about Rs 5 crore, with expected launch in February 2027 after commissioning.
The company stated it will invest Rs 200-300 crore over the next three years, and reserve Rs 30-40 crore per year for maintenance and improvements.
Management expects near-term demand challenges in Agrochemical Intermediates to persist, while non-agrochemical product groups are expected to maintain growth momentum, alongside continued raw material and shipping disruptions.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker